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Stress-induced impairments in extinction learning are believed to
sustain posttraumatic stress disorder (PTSD). Noradrenergic sig-
naling may contribute to extinction impairments by modulating
medial prefrontal cortex (mPFC) circuits involved in fear regula-
tion. Here we demonstrate that aversive fear conditioning rapidly
and persistently alters spontaneous single-unit activity in the
prelimbic and infralimbic subdivisions of the mPFC in behaving
rats. These conditioning-induced changes in mPFC firing were
mitigated by systemic administration of propranolol (10 mg/kg,
i.p.), a β-noradrenergic receptor antagonist. Moreover, proprano-
lol administration dampened the stress-induced impairment in ex-
tinction observed when extinction training is delivered shortly
after fear conditioning. These findings suggest that β-adrenoceptors
mediate stress-induced changes in mPFC spike firing that con-
tribute to extinction impairments. Propranolol may be a helpful ad-
junct to behavioral therapy for PTSD, particularly in patients who
have recently experienced trauma.
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Individuals exposed to extreme psychological stress, such ascombat-related trauma or sexual abuse, are at risk for de-
veloping anxiety and trauma disorders, including posttraumatic
stress disorder (PTSD). Although the etiology of PTSD is com-
plex, it is widely believed that associative learning processes,
including Pavlovian fear conditioning, contribute to its genesis.
Moreover, an inability to suppress or extinguish fear memo-
ries may sustain pathologically high levels of fear in patients
with PTSD years after the trauma (1–6). A variety of clinical
interventions to facilitate fear extinction in patients with PTSD
are currently being explored, although effective treatment for
many afflicted individuals remains elusive (7, 8).
One promising therapeutic target for facilitating extinction in
PTSD patients is the noradrenergic system. Norepinephrine
(NE) not only plays an important role in mood and arousal, but
also in the encoding, retrieval, and reconsolidation of emotional
memories (9–13). Endogenous NE signaling is elevated in PTSD
and drugs that block NE receptors are already being used with
some success to either prevent or treat PTSD, including its
symptoms of hyperarousal and nightmares (14–18). Clinically
effective noradrenergic drugs include the α1-adrenoceptor an-
tagonist, prazosin, and the β1/β2-adrenoceptor antagonist, pro-
pranolol (17, 19–21). The neural mechanisms underlying the
efficacy of these drugs remain poorly understood.
It has previously been suggested that stress-induced changes in
prefrontal cortical structure and function observed in animal
models may contribute to the extinction deficits observed in
patients with PTSD (22–24). Given the abundant literature im-
plicating NE signaling in prefrontal cortical function (25, 26), it is
conceivable that stress-induced elevations in prefrontal NE re-
lease (27–29) contribute to extinction impairments associated
with PTSD. The medial prefrontal cortex (mPFC), comprising
the prelimbic (PL) and infralimbic (IL) subdivisions in rodents,
plays a key role in the regulation of emotional behavior in both
humans and rats (30, 31). Previous studies have suggested that
PL plays an important role in fear expression, whereas IL is
preferentially involved in fear extinction (32–34). Stress-induced
alterations in the balance of neuronal activity in PL and IL as a
consequence of noradrenergic hyperarousal might therefore con-
tribute to extinction impairments and the maintenance of PTSD.
To address this question, we combine in vivo microelectrode re-
cording in freely moving rats with behavioral and pharmacological
manipulations to determine whether β-noradrenergic receptors
mediate stress-induced alterations in mPFC neuronal activity.
Further, we examine whether systemic propranolol treatment,
given immediately after an aversive experience, rescues stress-
induced impairments in fear extinction.
Results
Propranolol Stabilizes Medial Prefrontal Activity After Footshock
Stress. To investigate the effect of systemic noradrenergic block-
ade on stress-induced changes in the mPFC, we performed single-
unit recordings in freely moving rats (Materials and Methods).
Animals were first surgically implanted with a 16-channel micro-
electrode array (Innovative Neurophysiology) that spanned both
PL and IL (eight wires in each) in the right hemisphere of each
animal. Array placements in each rat are shown in Fig. 1A. The
recording sites varied somewhat in their mediolateral (i.e., laminar)
or dorsoventral position within PL and IL across rats. However,
there were no significant differences in single-unit firing or bursting
as a function of mediolateral or dorsoventral position within these
brain regions. Representative single-unit waveforms and their cor-
responding clusters from PL and IL are shown in Fig. 1B.
Significance
Posttraumatic stress disorder is characterized by a resistance to
extinction learning and dysregulated signaling of the neuro-
transmitter norepinephrine. Previous research suggested the
prelimbic and infralimbic subdivisions of the medial prefrontal
cortex (mPFC) regulate fear expression and suppression, re-
spectively. However, noradrenergic signaling in response to
psychological stress may disrupt mPFC function, contributing to
extinction deficits. Here we show, for the first time to our
knowledge, that footshock stress dysregulates mPFC spike fir-
ing; this can be stabilized by propranolol, a β-noradrenergic
receptor blocking drug, which in turn facilitates extinction
when it normally fails. These findings suggest that propranolol
may be a particularly effective adjunct to behavioral therapy
soon after trauma, when stress is high, at least in part by
normalizing prefrontal cortical function.
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After a 1-wk recovery period, rats were transported to the
recording chamber for the first of two recording sessions. During
the first recording session, the animals received a standard
Pavlovian fear conditioning procedure after systemic adminis-
tration of either vehicle or propranolol (10 mg/kg, i.p.); the
second session served as a retention test for conditioned fear.
For both recording sessions, rats were connected with a flexible
headstage cable to a multichannel OmniPlex recording system
(Plexon), and their freezing behavior was monitored inside a
standard conditioning chamber using a load-cell transducer and
amplifier (35). We recorded from a total of 220 mPFC neurons
on day 1 [vehicle (VEH)-PL, n = 52; VEH-IL, n = 34; pro-
pranolol (PROP)-PL, n = 85; PROP-IL, n = 49] and 185 neurons
on day 2 (VEH-PL, n = 47; VEH-IL, n = 34; PROP-PL, n = 63;
PROP-IL, n = 41). Although some of the units recorded on day 2
may have been the same as those recorded on day 1, we did not
assume that they were and treated them as a separate population
of neurons. The baseline firing rates of the units recorded on day
1 (mean ± SEM; 3-min predrug baseline) were as follows: VEH-
PL = 5.15 ± 0.78 Hz (range: 0.26–26.21 Hz); VEH-IL = 5.59 ±
0.88 Hz (range: 1.39–21.13 Hz); PROP-PL = 7.52 ± 0.75 Hz
(range: 0.28–41.09 Hz); PROP-IL = 8.60 ± 1.41 Hz (range: 0.46–
55.90 Hz). Although 23 cells had firing rates (>15 Hz; 10% of the
sample) typical of those observed in inhibitory interneurons, it
was not clear that these cells reflected a different population
when various rate and waveform parameters were examined and
they were consequently included in all analyses.
Drug administration before Pavlovian fear conditioning on
day 1 (Fig. 2A) did not significantly alter the spontaneous firing
rate of PL or IL neurons. Although firing rates decreased slightly
in all animals over the preconditioning recording period, this
decrease was similar in vehicle- and propranolol-treated rats
[main effect of time, F(2,432) = 15.57, P < 0.01; time × drug
interaction, not significant; time × drug × brain region interac-
tion, not significant]; this contrasts with a previous report that
found a significant decrease in PL firing with propranolol (36).
Average firing rates in the final 3-min block of the postinjection
period were as follows: VEH-PL = 4.73 ± 0.71 Hz; VEH-IL =
4.79 ± 0.92 Hz; PROP-PL = 7.17 ± 0.75 Hz; and PROP-IL =
7.36 ± 1.14 Hz.
Eighteen minutes after drug administration, the rats received
five pairings of an innocuous auditory conditioned stimulus (CS;
2 s, 2 kHz, 80 dB) with an aversive footshock unconditioned
stimulus (US; 0.5 s, 1.0 mA); trials were separated by a 1-min
intertrial interval (ITI). Fear conditioning was followed by a
60-min stimulus-free period during which the neural and be-
havioral effects of conditioning were recorded. Not surprisingly,
fear conditioning yielded robust increases in freezing behavior in
vehicle-treated rats. Interestingly, postshock freezing was signif-
icantly blunted by propranolol treatment [main effect of drug,
F(1,9) = 22.97, P < 0.01; Fig. 2B]. Correspondingly, fear condi-
tioning produced dramatic changes in the spontaneous firing rate
of PL and IL neurons and these conditioning-induced changes in
firing rate were dampened in propranolol-treated rats. Fig. 2C
shows firing rate histograms for representative single units in PL
and IL from vehicle- and propranolol-treated rats. In vehicle-
treated rats, fear conditioning produced substantial changes in
the firing rate in both PL and IL; these changes were minimal in
single units from propranolol-treated rats. This effect is partic-
ularly evident in heat maps illustrating the normalized firing rate
in the entire population of single units recorded on day 1 (Fig.
2D). A much greater proportion of neurons recorded in vehicle-
treated rats exhibited either markedly enhanced (light orange) or
suppressed (light blue) firing rates soon after fear conditioning
(t > 0) relative to units recorded in propranolol-treated rats.
To assess group differences in spontaneous firing rate, we gen-
erated average firing rate histograms for all of the units recorded in
each area and treatment condition (Fig. 3). In vehicle-treated rats,
fear conditioning massively, but transiently, increased the sponta-
neous firing rate among mPFC neurons in the minutes following
fear conditioning. These firing rate changes were mitigated by
propranolol-treatment in both PL [Fig. 3A; drug × time interaction,
F(178,24030) = 4.36, P < 0.01] and IL [Fig. 3B; drug × time in-
teraction, F(178,14418) = 2.82, P < 0.01]. For example, pro-
pranolol significantly attenuated conditioning-related increases in
PL in the first immediate postshock period [Fig. 3A, Inset; t(135) =
2.26, P < 0.05] and IL [Fig. 3B, Inset; t(81) = 1.98, P = 0.05] firing.
In addition to the rapid increases in IL and PL firing rate after
conditioning, IL neurons exhibited a sustained decrease in spon-
taneous firing that persisted (on average) for roughly 30 min after
conditioning. This decreased firing period corresponds to a time
window within which rats are resistant to extinction (23) and suggests
that shock-induced depression of IL activity may, at least in part,
account for this stress-induced immediate extinction deficit (IED).
Bursting of mPFC neurons has been implicated in both ex-
tinction learning (23, 36) and the IED (23). We therefore ex-
amined whether burst firing in PL and IL was modulated by
footshock stress and noradrenergic blockade. Although nor-
malized burst firing mirrored the patterns observed for overall
firing rate (Fig. S1), propranolol treatment did not reliably alter
shock-induced changes in burst firing in the immediate post-
shock period in PL neurons. This finding does not, however, rule
out the possibility that shock-induced changes in spontaneous
firing in mPFC are responsible for the IED.
Propranolol Mitigates Shock-Induced Increases and Decreases in
mPFC Firing Rate. Fear conditioning induced robust changes in
the average spontaneous firing rate of mPFC neurons. Nonethe-
less, individual single units exhibited considerable diversity in their
firing rate after fear conditioning (Fig. 2D). We were interested in
whether propranolol altered the proportion of neurons that in-
creased or decreased their firing rate after conditioning and
Fig. 1. In vivo mPFC recordings in freely moving rats. (A) Histological lo-
calization of the center of each electrode array in the mPFC; each array
targeted both PL (eight wires) and IL (eight wires). Right hemisphere, co-
ronal sections represent (left to right) coordinates +3.2 and +2.7 relative to
bregma in the anteroposterior plane. Six rats received propranolol (PROP)
treatment, and five received vehicle (VEH) treatment. In one of the pro-
pranolol rats, recordings were obtained only from PL. (B) Example voltage
trace from an electrode in PL (Upper) and IL (Lower), showing an action
potential and its corresponding principal component scatter plot.
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whether the magnitude of the firing rate changes in these pop-
ulations differed in the treatment conditions. We therefore cat-
egorized units in both PL and IL according to their response bias
in the immediate postshock interval (i.e., the 20-s period after
the final tone-shock pairing), as well as during a 20-s period at
the end of the 60-min postshock recording session.
There were no significant differences in the proportion of
neurons increasing or decreasing their firing rates in vehicle-
compared with propranolol-treated rats at either the immediate
(Fig. 4A) or remote time points (Fig. S2). However, despite in-
creasing their firing rates after conditioning, the majority of single
units in both PL and IL exhibited a suppression of firing 60 min
after conditioning (Fig. S2). This increase in the proportion of
neurons with suppressed firing rates across the recording session
was observed in both the PL [χ2(1) = 3.90, P < 0.05] and IL [χ2(1) =
4.98, P < 0.05] of vehicle-treated rats. In propranolol-treated rats,
this effect was only observed in PL neurons [χ2(1) = 10.38, P <
0.01], insofar as IL neurons were already more likely to be sup-
pressed immediately after conditioning. Overall, these data indicate
that the tendency for many neurons to show a transient increase in
firing rate in the immediate postshock period gave way to sup-
pression in rate by the end of the 60-min postshock period.
Although the proportion of neurons showing immediate post-
shock changes in firing was similar in vehicle- and propranolol-
treated rats, there were considerable differences in the firing rate
of these neurons (Fig. 4 B and C). Excited PL neurons in vehicle-
treated rats that exhibited immediate postshock increases in firing
rate showed a large but transient increase in firing in the post-
conditioning period; this effect was counteracted by propranolol
treatment [drug × time interaction, F(178,15308) = 5.68, P < 0.01;
Fig. 4B, Left]. Indeed, shock-induced increases in firing in the first
immediate postshock bin were significantly attenuated by pro-
pranolol treatment [t(86) = 2.56, P < 0.05; Fig. 4B, Left, Inset].
Similarly, excited IL neurons exhibited a transient increase in
firing in the postconditioning period that was attenuated in pro-
pranolol-treated rats [drug × time interaction, F(178,6230) = 2.71,
P < 0.01; Fig. 4B, Right]. However, this effect only approached
statistical significance in the first postshock bin [t(35) = 1.92, P =
0.06; Fig. 4B, Right, Inset].
Conditioning-induced decreases in firing were also sensitive to
propranolol treatment (Fig. 4C). In vehicle-treated rats, suppressed
Fig. 2. Propranolol stabilizes single-unit firing in mPFC neurons after footshock stress. (A) Day 1 experimental design. (B) Propranolol-treated rats (red circles)
exhibited reduced freezing throughout the day 1 recording session relative to vehicle-treated controls (white circles). (C) Four representative histograms (20-s
bins) showing spontaneous firing rate from neurons recorded in PL (Left) and IL (Right). Fear conditioning (blue bar) altered the firing rate of the PL and IL
neurons obtained from vehicle-treated rats (black traces, Upper) and propranolol administration mitigated this effect (red traces, Lower). (D) Normalized
firing rate heat maps showing postconditioning increases (light orange) and decreases (light blue) relative to baseline (preconditioning) firing rate (black) for
all of the units recorded in each group and brain region. Only the 3 min before conditioning and the first 5 min after conditioning are shown for clarity. In
both PL and IL, single units in vehicle-treated rats exhibited increases or decreases in firing rate after conditioning, and propranolol treatment mitigated these
effects. Injection (INJ) is denoted by green vertical bar; conditioning (tone-shock pairings) is denoted by blue vertical bar. Data during the conditioning period
were not recorded. All values are means ± SEM for freezing.
Fig. 3. Propranolol stabilizes single-unit firing in the population of mPFC
neurons. Spontaneous firing rates were averaged across all neurons and
normalized to the preconditioning baseline for each brain region and treat-
ment group. Fear conditioning (blue vertical bar) induced a dramatic in-
crease in average spontaneous firing rate in PL neurons from vehicle-treated
rats [A, black trace; Inset shows first 20-s postshock bin, comparing vehicle
(white bar) with drug (red bar)] that was mitigated by propranolol treat-
ment (A, red trace). Conditioning induced a weaker postshock increase in
spontaneous firing in IL neurons from vehicle-treated rats (B, black trace;
Inset shows first 20-s postshock bin) and produced an enduring suppression
of this activity. Propranolol treatment (B, red trace) counteracted both types
of firing rate changes in IL. Injection (INJ) is denoted by green vertical bar;
conditioning (tone-shock pairings) is denoted by blue vertical bar. Data
during the conditioning period were not recorded. *P < 0.05 vs. vehicle. All
values are means (±SEM for insets).





































PL neurons that exhibited immediate postshock decreases in rate
showed a decrease in firing in the postconditioning period that was
mitigated in propranolol-treated rats [drug × time interaction,
F(178,8366) = 1.33, P < 0.01; Fig. 4C, Left]. Firing during the
immediate postshock bin was significantly greater in propranolol-
treated rats [t(47) = 2.19, P < 0.05; Fig. 4C, Left, Inset]. Similarly,
propranolol treatment limited the magnitude of firing rate sup-
pression in IL neurons [drug × time interaction, F(178,7832) =
2.90, P < 0.01; Fig. 4C, Right], although this only approached sig-
nificance in the first immediate postshock bin [t(44) = 1.84, P =
0.07; Fig. 4C, Right, Inset]. In summary, noradrenergic blockade
stabilizes fear conditioning-induced changes in mPFC firing rate by
limiting both increases and decreases in spontaneous firing rate.
Expression of Conditional Freezing Is Not Sufficient to Increase mPFC
Firing Rate. Twenty-four hours after the first recording session, a
second session (day 2) was conducted to examine whether the
neural changes observed immediately after aversive conditioning
also occurred during the expression of fear to the CS. To this
end, rats were returned to the recording chamber, which was
modified to create a context that was distinct from that used for
conditioning (Fig. S3; see Materials and Methods for details).
After a 3-min baseline period, rats received five CS-alone trials
(i.e., without footshocks; 1-min ITI), and a subsequent 60-min
stimulus-free period. Both groups of rats exhibited high levels of
conditioned freezing in the 3-min period immediately after
presentation of the tones, indicating that systemic administration
of propranolol before fear conditioning the previous day did not
prevent the acquisition of conditioned fear (Fig. S3). There was
no significant effect of preconditioning drug treatment on day 1
on conditioned freezing behavior on day 2 (Fs < 1).
Importantly, CS presentations on day 2 produced qualitatively
different changes in spontaneous firing rate relative to day 1
despite yielding high levels of conditioned freezing behavior (Fig.
S3). After CS presentation, the majority of mPFC neurons in rats
that had been treated with vehicle the previous day showed de-
creases in firing rate (Fig. S3C), and this was most pronounced in
IL neurons. A significantly greater proportion of IL neurons was
suppressed in the vehicle- compared with propranolol-treated
animals [χ2(1) = 5.45, P < 0.05]. This pattern was also reflected
in the normalized firing rates across the recording session (Fig.
S3 D and E). Spontaneous firing tended to decrease in both PL
and IL after CS presentation, and propranolol administration
before fear conditioning on day 1 reliably dampened this effect
in IL [drug × time interaction, F(179,13067) = 2.25, P < 0.01].
This latter effect was particularly robust in the 20-s period im-
mediately after delivery of the last tone [t(73) = 2.14, P < 0.05;
Fig. S3E, Inset]. Similar to day 1, neuronal bursting largely
mirrored the spontaneous firing rate data. In addition to influ-
encing spontaneous firing rate on day 2, propranolol adminis-
tration before conditioning on day 1 significantly affected CS-
evoked firing during the tone presentations themselves (Fig. S4).
The fact that CS presentations on day 2 evoked robust freezing
behavior but minimally altered spontaneous firing in mPFC
suggests that a transition from a low fear state to a high fear state
is not responsible for the firing rate changes observed on day 1.
Fig. 5 illustrates this observation by plotting freezing behavior
and normalized firing rate across the two recording sessions.
Although the levels of freezing were similar immediately after
either CS-US (day 1) or CS-alone (day 2) trials on each day,
changes in neuronal activity were markedly different. On day 1,
vehicle-treated rats showed a postshock increase in spontane-
ous firing rate relative to propranolol-treated animals [main
effect of drug, F(1,216) = 8.41, P < 0.01]. This result contrasted
with day 2, where vehicle rats showed suppression of firing that
was counteracted by propranolol [main effect of drug, F(1,181) =
7.18, P < 0.01]. Thus, on both days, propranolol treatment miti-
gated changes in post-CS firing that were evident in vehicle-
treated rats.
Fig. 4. Propranolol stabilizes both increases and decreases in mPFC firing
rate. (A) Proportion of neurons in each of the four groups exhibiting im-
mediate postconditioning (first 20-s bin) increases (z > 0, excited) or de-
creases (z < 0, suppressed) in spontaneous firing rate. Regardless of drug
treatment, PL neurons tended to increase their firing rate after shock more
so than IL neurons. (B and C) Normalized firing rate histograms for PL (Left)
and IL (Right) neurons that were excited (B) or suppressed (C) in the im-
mediate postshock period in vehicle- (black traces) and propranolol-treated
(red traces) rats. Inset graphs show the values for the first 20-s postshock bin
in vehicle- (white bars) and propranolol-treated (red bars) rats. Injection (INJ)
is denoted by green vertical bar; conditioning (tone-shock pairings) is
denoted by blue vertical bar. Data during the conditioning period were not
recorded. *P < 0.05 vs. vehicle. All values are means (±SEM in insets).
Fig. 5. Freezing behavior does not alter mPFC firing rate. Freezing behavior
in both vehicle-treated (Left) and propranolol-treated (Right) rats was not
markedly different during the immediate postshock period on day 1 com-
pared with the immediate post-CS period on day 2 [values represent the
average freezing immediately following the last US (day 1) or CS (day 2)].
Despite similarities in day 1 and day 2 freezing, normalized firing rate during
the first 20 s following the last US (day 1) or CS (day 2) was dramatically
elevated in both IL and PL on day 1 relative to day 2 in vehicle-treated rats
(Left). This effect was mitigated by propranolol treatment (Right). Hence,
marked differences in firing rate in the mPFC cannot be attributed to
freezing behavior per se, because both posttrial periods (on day 1 and day 2)
yielded similar and high levels of freezing. All values are means ± SEM.
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Propranolol Facilitates Extinction Under Stress. We previously
established that extinction fails when given soon after footshock,
when levels of acute psychological stress are high; that is, rats
exhibit an IED when extinction trials are delivered soon after
fear conditioning (23, 37–39; but also see refs. 40 and 41). It is
notable that we now show that fear conditioning is followed by a
lasting suppression of IL firing (Fig. 3B), a time at which CS-
alone trials are ineffective at supporting long-term extinction
(37–39). We previously suggested that the IED results from a
high state of fear that interferes with mPFC function. Given that
systemic propranolol reduces shock-induced freezing and stabi-
lizes mPFC neural activity, we tested whether it would mitigate
the IED.
In this experiment, rats were systemically administered either
vehicle (n = 7) or propranolol (n = 7) immediately after fear
conditioning; an immediate extinction session consisting of 45
presentations of the CS (1-min ITI) was conducted 30 min after
conditioning. All rats were then given a retrieval test 48 h after
extinction using identical procedures to those used during the
extinction session (i.e., 45 CS-alone test trials). Both groups ac-
quired fear conditioning, and there were no differences in con-
ditioned freezing before drug treatment [Fig. 6A; F(1,12) < 1].
However, propranolol treatment before the immediate extinc-
tion session significantly reduced both pretrial (BL) and within-
session freezing during the extinction trials [Fig. 6B; main effect
of drug, F(1,12) = 8.40, P < 0.05] of the immediate extinction
session. Importantly, propranolol facilitated the acquisition of
long-term extinction; freezing in propranolol-treated rats was
significantly lower during the first nine-trial block of the retention
test [Fig. 6C, drug × time interaction, F(5,60) = 3.27, P < 0.05]. Thus,
propranolol treatment before the immediate extinction pro-
cedure limited the spontaneous recovery of fear that character-
izes the IED in vehicle-treated rats and promoted the retention
of extinction under conditions of high psychological stress that
normally impair extinction learning. Of course, in testing the
effects of propranolol on the IED, it is possible that propranolol
administered immediately after fear conditioning reduced con-
ditioned freezing by impairing the consolidation of the fear
memory, rather than facilitating extinction. To address this pos-
sibility, we conducted an additional experiment in which rats re-
ceived vehicle (n = 8) or propranolol (n = 8) immediately after
conditioning but did not receive extinction trials (Fig. 6 D–F). As
before, both groups acquired fear conditioning and exhibited
similar levels of conditioned freezing before drug treatment [Fig.
6D; main effect of group, F(1,14) < 1]. Thirty minutes after con-
ditioning, the rats were returned the conditioning chambers (con-
text B), but no extinction trials were delivered. Similar to the
previous IED experiment, propranolol-treated rats exhibited re-
duced freezing early in the session [Fig. 6E; drug × time interac-
tion, F(5,70) = 2.88, P < 0.05]. Importantly, during the fear recall
test 48 h after conditioning, there was no difference in conditioned
freezing between the groups [Fig. 6F; Fs < 1]. This finding indicates
that postconditioning propranolol did not impair consolidation of
the fear memory, an effect that is consistent with a previous report
(10). These data support the view that postconditioning pro-
pranolol facilitates immediate extinction by reducing postshock
fear and stabilizing mPFC firing.
If propranolol facilitates extinction learning under conditions
of high noradrenergic arousal, how might it affect learning when
the psychological stress level is presumably lower? To address
Fig. 6. Propranolol mitigates the immediate extinction deficit. Propranolol administration immediately after fear conditioning (A) reduced both baseline
(BL) and freezing during the immediate extinction session (B, 30 min after conditioning). Propranolol facilitated the recall of extinction during a retention test
conducted 48 h after extinction (vehicle, n = 7; propranolol, n = 7) (C). This effect on freezing was not due to impaired consolidation of the fear conditioning
memory. Rats that were administered propranolol immediately after conditioning (D), but not extinguished exhibited reductions in freezing early in the no-
extinction session (E, context exposure only) and high levels of freezing during the retention test that did not differ from vehicle-treated controls (vehicle, n =
8; propranolol, n = 8) (F). Gray bars denote the 3-min baseline (BL) period before delivery of conditioning or extinction trials. *P < 0.05 vs. propranolol. All
values are means ± SEM.





































this question, we conducted another experiment in which rats
received vehicle or propranolol (n = 8 per group) before delayed
extinction (24 h after conditioning). As shown in Fig. 7, freezing
behavior before the first CS trial during the extinction session
was low (Fig. 7B) in both vehicle- and propranolol-treated rats.
This finding indicates that delayed extinction limits the high
levels of sensitized fear observed with the immediate extinction
procedure (Fig. 6 B and E). In addition, propranolol adminis-
tration did not influence either the expression of fear or within-
session extinction [Fig. 7B; Fs < 2], consistent with the sug-
gestion that basal noradrenergic arousal must be high in order
for propranolol to limit freezing. However, propranolol-treated
rats exhibited impairments in extinction recall during the re-
tention test 24 h after extinction. Specifically, rats in the pro-
pranolol group exhibited greater levels of freezing during the
first block of nine trials of the session relative to vehicle-treated
rats [Fig. 7C; drug × time interaction, F(5,70) = 2.84, P < 0.05].
Thus, propranolol given before delayed extinction impaired,
rather than enhanced, learning during this putatively lower state
of psychological stress.
Discussion
Stress-induced extinction deficits, including the IED, have been
posited to arise from dysregulation of mPFC function (23, 39,
42). In support of this hypothesis, the present experiments reveal
that footshock stress accompanying fear conditioning produces
dramatic changes in both the firing rate and bursting profile
of single units recorded in PL and IL. Systemic β-adrenergic
blockade by propranolol counteracts these effects by maintaining
a relative balance in PL and IL neural activity after the footshock
stressor. In addition, propranolol administration rescued the
IED, suggesting that noradrenergic stabilization of mPFC ac-
tivity buffers against the deleterious effects of stress on extinction
learning. This previously unidentified finding has important im-
plications for understanding how β-noradrenergic interventions
minimize the deleterious effects of marked psychological stress
or trauma and improve psychotherapeutic outcomes (17, 18).
Moreover, these data suggest that propranolol may be partic-
ularly effective in facilitating fear reduction when prevailing
stress at the onset of extinction training is high. Thus, the timing
of propranolol administration may be critical to maximizing its
therapeutic efficacy in the treatment of stress- or trauma-related
disorders such as PTSD.
It has previously been suggested that PL and IL have opposing
roles in the regulation of fear (23, 32–34, 43). The present data
lend some support to this view insofar as the expression of
freezing behavior after conditioning was associated with distinct
patterns of firing among simultaneously recorded neurons in PL
and IL. Immediately after the last fear conditioning trial on day
1, PL neurons (on average) exhibited a massive, but transient
increase in spontaneous firing rate. In contrast, IL neurons (on
average) exhibited a weaker increase in firing rate, followed by a
sustained decrease in firing that persisted for much of the re-
cording session. Hence, a shift in the balance of PL and IL ac-
tivity accompanied both the induction and maintenance of
freezing behavior in the aftermath of conditioning. However, it is
important to note that sustained decreases in IL firing, rather
than sustained increases in PL firing, were associated with the
maintenance of freezing behavior. This observation suggests that
regulation of IL-mediated inhibition of amygdala excitability, for
example, is not only involved in the expression of extinction (44),
but also the expression of conditioned fear. Consistent with the
sustained changes in firing rate we observed after footshock, a
study of restraint stress in rats found that a population of mPFC
neurons showed an increase in firing rate that persisted for over
2 h after the stressor (45).
Surprisingly, fear-related changes in mPFC firing were quali-
tatively different after fear conditioning than after the pre-
sentation of fear CSs. Neurons in both IL and PL exhibited much
more dramatic changes in spontaneous firing immediately after
CS-US pairings on day 1 than after presentation of the CS alone
on day 2, despite similar (and nearly asymptotic) levels of freezing
behavior in each session, particularly in vehicle-treated rats. These
results indicate that it is not high levels of fear per se that correlate
with changes in mPFC neuronal firing (23, 24, 32–34), but rather
the emotional context in which that fear is experienced (46, 47).
Specifically, our results suggest that mPFC firing is particularly
sensitive to the acute effects of the footshock US, possibly
reflecting unconditioned components of fear in the immediate
aftermath of shock exposure. Experiments examining the conse-
quences of footshock delivery immediately on placement in the
recording chamber (i.e., an immediate shock procedure that yields
little freezing) would help to resolve this issue (48, 49). Collec-
tively, our results reveal that, whereas recent exposure to foot-
shock strongly modulates neuronal firing in mPFC, exposure to
the CS alone does not. It should also be noted that within-session
spontaneous firing rates in PL and IL did not correlate with on-
going freezing behavior (and by inference, fear state). For exam-
ple, firing rates in both PL and IL largely returned to baseline by
the end of the first recording session, despite the fact that freezing
behavior remained markedly elevated relative to the preshock
baseline. This finding suggests that circuits other than mPFC
mediate the sustained freezing behavior we observed, although PL
and IL may initiate or otherwise contribute to this effect.
Fig. 7. Propranolol impairs delayed extinction. In contrast to its effects on immediate extinction, propranolol given 30 min before a delayed extinction
session, which took place 24 h after conditioning (A) did not significantly alter within-session extinction (B). Moreover, propranolol-treated rats exhibited a
deficit in extinction recall 24 h after extinction (C) (vehicle, n = 8; propranolol, n = 8). Gray bars denote the 3-min baseline (BL) period before delivery of
conditioning or extinction trials. *P < 0.05 vs. vehicle. All values are means ± SEM.
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Because β-adrenergic receptors have previously been impli-
cated in stress-induced modulation of prefrontal function (50),
we next examined whether systemic propranolol administration
affected shock-induced changes in PL and IL firing. We found
that propranolol administration before fear conditioning stabi-
lized spontaneous activity in PL and IL after footshock, damp-
ening the magnitude of shock-induced spike firing changes
observed among single-units in each area. Specifically, pro-
pranolol both attenuated the immediate postshock increases in
firing rate in PL, as well as the decreases in IL firing that ac-
companied the expression of fear during the remainder of the
session. This observation suggests that propranolol may reduce
fear after conditioning, at least in part, by stabilizing neuronal
firing in PL and IL in the aftermath of footshock.
Indeed, the stabilizing effect of propranolol on PL and IL
spike firing may underlie the facilitation of extinction that we
observed behaviorally when this drug was given before immedi-
ate extinction. That is, propranolol administered immediately
after fear conditioning reduced the expression of freezing be-
havior during the immediate extinction session and facilitated
lasting extinction. This effect was not due to an effect of pro-
pranolol on fear memory consolidation (10) as the drug had no
effect on conditioned freezing in animals that did not undergo
extinction. Similar to our results, Quirk and colleagues observed
decreases in freezing behavior after systemic propranolol ad-
ministered before an extinction session that was conducted 24 h
after conditioning (36). Interestingly, however, they found no
lasting effect of propranolol on extinction under these conditions
(36) and, in a related study, they reported extinction impairments
after intra-IL propranolol infusion (51). We suggest that the dis-
parities in these results are related to the timing of extinction and
propranolol administration relative to fear conditioning. Specifi-
cally, propranolol administration soon after conditioning facilitates
immediate extinction by dampening shock-induced noradrenergic
arousal (27–29, 52), whereas propranolol administration long after
conditioning, when noradrenergic arousal is low, impairs extinction
learning by reducing adrenergic transmission below optimal levels
(25). This latter hypothesis is consistent with the present data
showing that propranolol administered before delayed extinction
actually impairs learning. Collectively, our data suggest that pro-
pranolol administered during stress stabilizes PL and IL activity
and facilitates extinction learning.
Of course, a critical question is whether the β-adrenergic re-
ceptors mediating the effects of systemic propranolol are located
in the mPFC or in other brain regions that regulate the mPFC
including the locus coeruleus (LC) and basolateral amygdala
(BLA) (53). Consistent with the former possibility, IL infusion of
propranolol has been reported to influence extinction recall (51);
however, it is not known whether this manipulation facilitates
immediate extinction. Alternatively, noradrenergic modulation
of BLA excitability (53) may influence mPFC firing to regulate
extinction. Consistent with this possibility, it has been found that
induction of inflammatory pain decreases mPFC firing, a change
that was mediated by hyperexcitability in the BLA (54). Indeed,
other stressors have also been reported to modulate mPFC
through the amygdala (55), and the BLA regulates fear and
extinction through its long-range projections to mPFC (56).
Ultimately, stress-induced NE release from LC terminals, which
has been broadly implicated in the regulation of memory and
emotion (53), may influence mPFC spike firing either directly or
through indirect modulatory circuits.
The present experiments have critical implications for de-
veloping pharmacotherapeutic interventions for anxiety- and
trauma-related disorders in humans. For example, a commonly
used, albeit controversial approach to prevent PTSD is so-called
psychological debriefing, in which behavioral therapy is given
soon after exposure to a traumatic event (57–59). Administration
of noradrenergic pharmacological agents, such as propranolol,
soon after trauma could enhance the effectiveness of debriefing
or other early interventions by modulating prefrontal cortical
activity as we have described here. Consistent with this, it has
been reported that propranolol treatment within days of trauma
in humans reduces the incidence of PTSD (21). Moreover,
propranolol administered after trauma reactivation in patients
with PTSD has a therapeutic effect on physiological responding
to traumatic imagery weeks after the pharmacological interven-
tion (17, 18). Together, these studies suggest that propranolol
administration may be particularly effective when trauma-related
arousal is high (i.e., soon after trauma and after trauma reac-
tivation). The present data suggest that the efficacy of pro-
pranolol under these conditions would be greatly enhanced by
concurrent exposure therapy.
In summary, exposure to footshock stress initiates pronounced
signaling changes in mPFC and freezing behavior and β-norad-
renergic blockade by propranolol mitigates these effects. Col-
lectively, these findings shed light on prefrontal executive control
of fear-related behavior while also suggesting that propranolol
treatment may enhance behavioral debriefing aimed at pre-
venting PTSD development after recent exposure to trauma.
Materials and Methods
Subjects. Adult male Long–Evans Blue Spruce rats (weighing 200–224 g; 50–
57 d old) were obtained from a commercial supplier (Harlan Sprague–
Dawley). On arrival and throughout the experiments, these experimentally
naïve rats were individually housed in cages within a temperature- and
humidity-controlled vivarium and kept on a 14:10-h light/dark cycle (lights
on at 7:00 AM) with ad libitum access to food and water. All experiments
took place in the daytime during the light phase. Rats were handled for
∼30 s a day for 5 d before any behavioral testing or surgical procedures were
carried out to habituate them to the experimenter. The number of rats used
in each experiment is stated in the figure legends. All experiments were
conducted at Texas A&M University with full approval from its Animal Care
and Use Committee.
Drugs. D,L-Propranolol hydrochloride was obtained from a commercial sup-
plier (Sigma-Aldrich). The drug was dissolved in distilled water (5 mg/mL)
and injected systemically (10 mg/kg, i.p.) in a volume of 2 mL/kg.
In Vivo Electrophysiology. Twelve rats (vehicle, n = 6; propranolol, n = 6) were
used for the electrophysiological experiments; one rat in the vehicle group
died before completing the experiment leaving five rats in that group. Rats
were assigned to each drug condition such that each condition was alter-
nated across the experiment. For implantation of the recording array, rats
were anesthetized with isoflurane (5% induction, 2% maintenance) and
secured in a stereotaxic apparatus (Kopf Instruments). The scalp was incised
and retracted; three burr holes were drilled for anchor and ground screws. A
portion of the skull overlying the mPFC was removed to allow for micro-
electrode implantation. The rat was implanted with a 16-channel micro-
electrode array (Innovative Neurophysiology) targeting both the PL (eight
wires) and IL (eight wires) subdivisions of the mPFC in the right hemisphere.
The 2 × 8 wire microarray was constructed from two rows of 50-μm-diameter
tungsten wires of two different lengths (PL, 6.9 mm; IL, 8.0 mm); wires in each
row and the rows themselves were spaced 200 μm apart. The array was po-
sitioned with its long axis parallel to the anterior-posterior plane. The co-
ordinates for the centermost wires of the array were as follows: PL, +2.7 mm
AP, +0.55 mm ML, −4.0 mm DV and IL, +2.7 mm AP, +0.35 mm ML, −5.1 mm
DV (relative to bregma at skull surface). The mediolateral offset (200 μm)
between the PL and IL electrode rows minimized damage to the overlying
cortex during array implantation. Also, the slightly more medial coordinate of
the IL wires, relative to the PL ones, accommodates the slightly thinner IL
cortex, allowing recordings in similar layers in the two brain areas within a
given rat. The array was secured to the skull with dental acrylic and one week
was allowed for recovery before in vivo recordings began.
A standard rodent conditioning chamber (30 × 24 × 21 cm; Med Asso-
ciates) housed in a sound-attenuating cabinet was modified to allow for
electrophysiological recordings. The chamber consisted of two aluminum
sides, a Plexiglas rear wall, and a hinged Plexiglas door. The grid floor con-
tained 19 stainless steel rods (4 mm diameter) spaced 1.5 cm apart (center-to-
center). Rods were connected to a shock source and solid-state grid scram-
bler (Med Associates) for the delivery of footshocks. A loudspeaker mounted





































on the outside of a grating in one aluminum wall was used to play au-
ditory tones. Locomotor activity was transduced by a load cell under the
floor of the chamber, and the output of the load cell was recorded by an
OmniPlex recording system (Plexon). The experimenters were not blind
to drug treatment group, but all behavioral and neural activity was
recorded automatically.
Single-unit recordings occurred over 2 d in two distinct contexts. On day 1,
the rats were transported to the recording room in a black box, connected to
the headstage cable, and placed in the recording chamber. The chamber was
cleaned with 1% ammonium hydroxide to provide a distinct olfactory cue, a
black pan containing a thin layer of the same solution was placed under the
grid floor, and the room was illuminated with ambient red lights (context A).
After a 3-min stimulus-free baseline period, the rat was briefly removed from
the chamber and injected with either propranolol (10 mg/kg, i.p) or vehicle
(distilled water) and then immediately returned to the recording chamber.
Neural and behavioral data were not recorded during injection (∼1 min) due
to the electrical noise associated with handling the rat. Twenty minutes after
the injection (36), five tone (2 s, 80 dB, 2 kHz)–footshock (0.5 s, 1 mA) trials
were delivered (shock onset occurred at tone offset) with a 1-min ITI. Be-
havioral and neuronal data were not recorded during the conditioning pe-
riod due to the electrical noise associated with shock delivery; recordings
commenced immediately after the last footshock. The recording session
continued for 60 min after the last footshock, after which the rat was
returned to its home cage.
On day 2, the transport and recording contexts were altered to reduce
generalization of fear from the conditioning session to the test session. The
rat was transported in a white box. The recording chamber was cleaned with
1% acetic acid to provide a distinct olfactory cue, a white pan containing a
thin layer of the same solution was placed under the grid floor, the grid floor
was covered with a transparent rubber mat, the back wall was covered with
alternating black and white stripes, and the room was illuminated with
ambient fluorescent lights (context B). After a 3-min stimulus-free baseline
period, the rat was presented with five tone-alone trials (1-min ITI; all tone
parameters were the same as on day 1); the rat remained in the chamber for
60 min after the final tone, and behavioral and neuronal data were recorded
throughout the session.
Extracellular single-unit activity was recorded using a multichannel neu-
rophysiological recording system (OmniPlex; Plexon). Wideband signals
recorded on each channel were referenced to one of the recording wires
(resulting in 15 channels of activity per rat), amplified (8,000×), digitized
(40 kHz), and saved on a PC for offline sorting and analysis. The recording
reference wire was located in PL and was randomly selected to optimize
the quality of the recordings. After high-pass filtering the signal at 600 Hz,
waveforms were sorted manually using 2D principal component analysis
(Offline Sorter; Plexon). Only well-isolated units were used in the analysis. If
two units with similar waveforms and identical time stamps for their action
potentials appeared on adjacent electrodes, only one unit was used. Sorted
waveforms and their timestamps were then imported to NeuroExplorer (Nex
Technologies) for analysis.
The analysis of neuronal activity focused on spontaneous single-unit firing
and bursting during each recording session; CS-evoked activity was also
analyzed on day 2. To compute firing rate histograms, spike rates were
binned (20 s) and normalized (z-scores) to control for differences in baseline
firing rate. On day 1, firing rate was normalized to the entire pre-
conditioning period (3-min preinjection and 20-min postinjection periods).
On day 2, the data were normalized to the 3-min baseline period before CS
presentations. For the burst analyses, a burst was defined as two spikes with
an interspike interval of <25 ms followed by a third spike within 50 ms of the
second spike (60); bursts could continue if additional spikes occurred within
50-ms intervals of one another.
IED and Delayed Extinction Experiments. Sixteen adult Long–Evans (Blue Spruce)
rats served as subjects. All behavioral training was conducted in two adjacent
rooms, each containing eight identical conditioning chambers (same dimen-
sions as for the in vivo recordings). Video cameras mounted above the be-
havioral chambers were used to monitor the animals during each session.
Each chamber rested on a load cell platform that transduced locomotor ac-
tivity (Med Associates). Load cell activity was digitized (Threshold Activity
Software; Med Associates) and transformed as previously described to mea-
sure freezing behavior. Rats received three phases of training. They first
received fear conditioning (context A, room 1) followed 30 min later by an
immediate extinction session (context B, room 2). An extinction retrieval
test (context B, room 2) was conducted 48 h after extinction. Contexts had
distinct olfactory and visual cues, similar to those described above.
Fear conditioning consisted of a 3-min stimulus-free baseline period, fol-
lowed by five tone (10 s, 80 dB, 2 kHz)–shock (2 s, 1 mA) pairings (1min ITI); the
rats remained in the chambers 3 min after the last trial. Immediately after
conditioning, half the rats received systemic administration of propranolol
(n = 8, 10 mg/kg, i.p.) and the other half received vehicle (n = 8, distilled water);
after injection, they were returned to their home cages in the vivarium. Thirty
minutes after fear conditioning, the rats were returned to a novel room and
context (context B) and presented with 45 tone-alone trials (1-min ITI; same
tone parameters as during fear conditioning) after a 3-min baseline. All rats
were given a subsequent extinction retrieval session (retention test; context B;
same tone parameters as before) 48 h after conditioning to assess long-term
extinction memory. One rat from each group exhibited levels of conditioned
freezing during the retention test that was ±2 SD from the group mean;
these statistical outliers were excluded from the analysis.
In a second behavioral experiment (no extinction) with 16 adult Long–
Evans rats, we examined whether postconditioning propranolol treatment
interferes with fear memory consolidation. The experiment was identical to
that described in preceding IED experiment, except that CS-alone trials were
not delivered 30 min after conditioning, although rats were still placed in
the extinction context. Rats did receive a retention test 48 h later, in which
the CSs were administered.
A third experiment examined delayed extinction (16 adult Long–Evans
rats), in which the extinction session took place 24 h after fear conditioning
and propranolol or vehicle was given 30 min before extinction. A retention
test was then given 24 h after extinction.
Histology. After the completion of experiments, recording rats were over-
dosed with pentobarbital, and electrolytic lesions (80 μA, 10 s; A365 stimulus
isolator; World Precision Instruments) were generated through six of the
recording wires to mark the location of the recording array in the medial
prefrontal cortex. The rats were then perfused transcardially with 0.9% sa-
line followed by 10% formalin (10% formaldehyde by volume, diluted in
physiological saline). Brains were extracted from the skull and postfixed in a
10% formalin solution for 24 h followed by 10% formalin/30% sucrose so-
lution [30% sucrose (wt/vol), diluted in 10% formalin solution] where they
remained for a minimum of 48 h. After the postfix period, brains were
sectioned (50 μm) on a cryostat (−20 °C), mounted on subbed microscope
slides, and stained with thionin (0.25%) to visualize electrode placements.
Statistics. Data were analyzed with conventional parametric statistics (Stat-
View; SAS Institute). Two-way ANOVA and repeated-measures ANOVA were
used to assess general main effects and interactions (α = 0.05). Unpaired
Student’s two-tailed t tests were also used for pairwise comparisons of
means. Results are shown as means ± SEMs.
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